Journal article

SCN1A testing for epilepsy: Application in clinical practice

Shinichi Hirose, Ingrid E Scheffer, Carla Marini, Peter De Jonghe, Eva Andermann, Alica M Goldman, Marcelo Kauffman, Nigel CK Tan, Daniel H Lowenstein, Sanjay M Sisodiya, Ruth Ottman, Samuel F Berkovic



Awarded by International League Against Epilepsy from Japan Society for the Promotion of Science (JSPS)

Awarded by Ministry of Health, Labour and Welfare

Funding Acknowledgements

We thank Dr. Christoph Lossin (US Davis, CA) for his valuable suggestions. This work was supported in part by the International League Against Epilepsy, a Grant-in-Aid for Scientific Research (A) 21249062, a Grant-in-Aid for for Challenging Exploratory Research 23659529, a Grant-in-Aid for Bilateral Joint Research Projects from Japan Society for the Promotion of Science (JSPS); Research Grants (21B-5) for Nervous and Mental Disorder, and Health and Labour Science Research Grant 21210301, KB220001 and Grant-in-aid for the Research on Measures for Intractable Diseases, No. H22-Nanji-Ippan-49 from the Ministry of Health, Labour and Welfare; Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research, Japan Science and Technology Agency (JSP); and Research grant from the Japan Epilepsy Research Foundation. This report was written by experts selected by the International League Against Epilepsy (ILAE) and was approved for publication by the ILAE. Opinions expressed by the authors, however, do not necessarily represent official policy or position of the ILAE.